Clinical Trial Update: Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of dapagliflozin on atrial fibrillation recurrence in patients undergoing Cox Maze IV procedure; current status not discl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Kun Hua | Conditions: Atrial Fibrillation Recurrence, Cox Maze IV | Phase 4 | Status: UNKNOWN